BioXcel Therapeutics, Inc. revenue breakdown overview

BioXcel Therapeutics, Inc. revenue for the last year amounted to 1.38 M USD, the most of which — 1.38 M USD — came from its highest performing source at the moment, Neuroscience and Immuno-oncology Drugs, the year earlier bringing 375.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought BioXcel Therapeutics, Inc. 1.38 M USD, and the year before that — 375.00 k USD.